Tom Dumoulin of Giant-Alpecin has criticised Bradley Wiggins’ decision to seek a Therapeutic Use Exemption (TUE) to take the powerful corticoid triamcinolone before targeting the most important Grand Tours in his career.
Wiggins has been forced to defend his decision to take the drug after a week of criticism from a range of former riders, team doctors and even former UCI president Pat McQuaid, who criticised Team Sky for bending the rules.
Wiggins' TUE use was revealed by the Russian Fancy Bears hackers who broke into the World Anti-Doping Agency (WADA) records. His TUE forms showed that the intramuscular injections were authorised to treat asthma symptoms. It seemed a drastic measure, with other experts insisting that doctors should have been able to manage his illness using standard inhalers.
ADVERTISEMENT
There is no suggestion that either Wiggins or Team Sky have broken any rules and the Briton's TUE was approved by the UCI doctor at the time. However, Dumoulin went as far as saying the whole thing “stinks.”
Wiggins defended his decision to take triamcinolone, arguing it was for legitimate reasons.
"This was to cure a medical condition. This wasn't about trying to find a way to gain an unfair advantage. This was about putting myself back on a level playing field in order to compete at the highest level,” Wiggins said during the interview on the Sunday morning Andrew Marr political chat show on the BBC.
You can read more at Cyclingnews.com
via Cyclingnews Latest News http://ift.tt/2dl0nB5
No comments:
Post a Comment